Bendamustine approved by FDA for chronic lymphocytic leukemia
Article
Bendamustine has been approved by the FDA for the treatment of CLL
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.